At ESC Congress 2023 we will be 'joining forces to protect the heart' and create the future of cardiology – a future where everything is possible.

Dr Jorg Taubel will be attending in person along with Dr Julian Gilmore from the Royal Free London NHS Foundation Trust who will be presenting ‘ATTRibute-CM: acoramidis (AG10) in patients with transthyretin amyloid cardiomyopathy’ 

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event